论文部分内容阅读
目的探讨70例儿童病毒性呼吸道感染患者经抗毒药物治疗后的临床疗效并分析其安全性。方法本院儿科2011年4月10日-2012年12月10日接收70例儿童病毒性呼吸道感染患者,随机分为抗毒中药组(A)和抗病毒西药组(B),每组各35例。A组服用午时茶颗粒,B组服用利巴韦林颗粒。观察两组服用抗毒药物后的临床疗效,评价两组服用药物后的安全性。结果 A组的临床疗效B组相比差异显著(P<0.05),具有统计学意义,且A组的临床疗效高于B组。两组的安全性评价无明显差异(P>0.05)。结论中药抗病毒药物治疗儿童病毒性呼吸道感染不失为一种理想的方法,疗效好且安全性高,不良反应少,尤其适用于儿童,是儿童患者值得选择的优良方案。
Objective To investigate the clinical efficacy of anti-virus drugs in 70 children with viral respiratory tract infections and to analyze their safety. Methods A total of 70 children with viral respiratory infection were enrolled from April 10, 2011 to December 10, 2012. The children were randomly divided into anti-drug group (A) and anti-virus group (B) example. Group A took afternoon tea granules, Group B took ribavirin granules. The clinical efficacy of the two groups after taking antitoxic drugs was observed to evaluate the safety of the two groups after taking the drugs. Results The clinical efficacy of group A was significantly lower than that of group B (P <0.05), which was statistically significant. The clinical efficacy of group A was higher than that of group B. There was no significant difference in safety evaluation between the two groups (P> 0.05). Conclusion Chinese medicine antiviral treatment of children with viral respiratory tract infection is an ideal method, good efficacy and high safety, fewer adverse reactions, especially for children, is an excellent program worthy of choice in children.